Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-029640

Director sold 22,000 shares at $10.05 ($221,025)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2026-05-01 Sale 10b5-1 −22,000 $10.05 $221,025 1,078,391 D
Open-market sales · 22,000 sh · avg $10.05 · $221,025
Loading xslF345X06/wk-form4_1777912538.xml…